Clinical

Dataset Information

0

Chemoembolization (Lifepearls-Irinotecan) in Patients With Colorectal Cancer and Metastatic Disease


ABSTRACT: Non-commercial, prospective, randomized, multicenter, national, phase II, open-label comparative clinical trial. The patients will be randomized in a 1: 1 ratio in two arms: Control arm. Systemic chemotherapy with FOLFOX6m + monoclonal Ab Experimental arm. Systemic chemotherapy with FOLFOX6m + monoclonal Ab + Intra-arterial liver chemotherapy with LIFEPEARLS-IRINOTECAN (catheterization and infusion of 100 +/- 50 micron microspheres loaded with 100 mg of irinotecan in both liver lobes) cycles 2 and 4. The main objective is to evaluate the radiological objective response rate according to the RECIST version 1.1 criteria at 6 months. Secondary objectives include: Evaluate overall survival, progression-free survival (PFS), safety profile, hepatic PFS, R0 liver surgery rate.

DISEASE(S): Neoplasm Metastasis,Liver Metastasis Colon Cancer,Colorectal Cancer,Colorectal Cancer Metastatic,Colorectal Neoplasms

PROVIDER: 2355124 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

2019-05-03 | GSE72484 | GEO
2013-01-15 | E-MTAB-951 | biostudies-arrayexpress
2019-01-23 | GSE102995 | GEO
2018-11-21 | GSE110785 | GEO
2014-11-14 | E-GEOD-36864 | biostudies-arrayexpress
2011-10-21 | E-GEOD-25192 | biostudies-arrayexpress
2013-12-18 | E-GEOD-53127 | biostudies-arrayexpress
2019-09-27 | PXD015369 | Pride
2011-10-22 | GSE25192 | GEO
2014-11-14 | GSE36864 | GEO